# Echo Immune

Source: https://onco.cc/companies/echo-immune/  
OnCo record `echo-immune` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Echo Immune is developing personalised mRNA cancer vaccines designed from a patient's own tumour to stop cancer coming back after treatment.

## Summary

Echo Immune's stated focus is recurrence: a tumour carries a unique molecular signature, surgery or therapy removes most of it, and the vaccine is meant to teach the immune system to recognise what is left. The company makes personalised mRNA cancer vaccines for the individual patient, the approach that BioNTech and Moderna have taken into phase 3 in melanoma. It is an Even One Ventures portfolio company and has not published trials.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: startup; evenone-portfolio; oncology
- HQ: United States (head office not published)
- Type: biotech
- Website: https://www.echoimmune.com/

## Sources

- Official website: https://www.echoimmune.com/
- Even One Ventures portfolio: https://evenone.ventures/

## Connected records

- technologies: [Personalised neoantigen (mRNA) vaccines](https://onco.cc/technologies/neoantigen-mrna-vaccine/)
- companies: [Even One Ventures](https://onco.cc/companies/evenone-ventures/)

---
JSON: https://onco.cc/api/v1/entities/echo-immune.json